Iranian Journal of Otorhinolaryngology

Iranian Journal of Otorhinolaryngology

The Efficacy of Bethesda System for Prediction of Thyroid Malignancies- A 9 Year Experience from a Tertiary Center

Document Type : Original

Authors
Hamdan Ahmed Pasha 1
Ainulakbar Mughal 2
Muhammad Wasif 2
Rahim Dhanani 2
Syed Arish Haider 3
Sayed Akbar Abbas 2
1 Department of Otolaryngology Head and Neck Surgery, Jinnah Medical College Hospital, Karachi, Pakistan.
2 Department of Otolaryngology Head and Neck Surgery, Aga Khan University Hospital, Karachi, Pakistan.
3 Department of Postgraduate Medical Training, Aga Khan University Hospital, Karachi, Pakistan.
10.22038/ijorl.2021.50538.2687
Abstract
Introduction:
The best initial investigation for thyroid nodule is fine needle aspiration (FNA). Bethesda System is an international standardized system of reporting thyroid nodules and recommends subsequent management. Every institution should assess the risk of malignancy in each category to avoid unnecessary thyroid surgeries, with this aim we conducted a review at our center to calculate risk of malignancy in each category.
 
Materials and Methods:
Retrospective 9-year (2009–2018) review of thyroid FNAs done at a tertiary care Centre. The FNA was stratified according to The Bethesda System. Histopathology reports of the operated cases were used to evaluate the cytology for diagnostic accuracy.
 
Results:
There were 495 patients who underwent thyroidectomy. The mean age of the cohort was 42.51 +/- 13.2 years and 387 (78.2%) were females. The frequency of Bethesda categories I, II, III, IV, V, and VI were 9.1%, 55.6%, 16.4%, 6.5%, 9.3%, and 3.2% respectively. Malignancy rate in operated thyroid nodules were 37.8%, 8.4%, 33.3%, 50.0%, 89.1%, and 100% for Bethesda categories I to VI, respectively. The sensitivity, specificity, negative predictive value and positive predictive value and their 95% CIs were calculated as 81.30 (73.28 – 87.76%), 77.06 (72.12 – 81.51%), 91.64 (88.3 – 94.1%) and 57.14 (51.79 – 62.33%). The overall diagnostic accuracy was 78.22 (74.12 – 81.95%).
 
Conclusions:
All the Bethesda categories showed greater malignancy risks than other reported studies. Knowledge of local rates of malignancy is important to accurately predict the risk of malignancy even when reported with internationally accepted nomenclature like the Bethesda System.
Keywords
Bethesda
Fine needle aspiration
Malignancy risk
Thyroid nodule
  1. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Archives of internal medicine. 1994;154(16):1838-40.
  2. Tepeoğlu M, Bilezikçi B, Bayraktar S. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases. Cytopathology. 2014;25(1):39-44.
  3. Cibas ES. Fine-needle aspiration in the work-up of thyroid nodules. Otolaryngologic Clinics of North America. 2010;43(2):257-71.
  4. Haberal A, Toru S, Özen Ö, Arat Z, Bilezikçi B. Diagnostic pitfalls in the evaluation of fine needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases. Cytopathology. 2009; 20(2):103-8.
  5. Sakorafas GH. Thyroid nodules; interpretation and importance of fine-needle aspiration (FNA) for the clinician–Practical considerations. Surgical oncology. 2010;19(4):e130-e9.
  6. Rabaglia JL, Kabbani W, Wallace L, Holt S, Watumull L, Pruitt J, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery. 2010; 148(6):1267-73.
  7. Pang T, Ihre-Lundgren C, Gill A, McMullen T, Sywak M, Sidhu S, et al. Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. Surgery. 2010; 148(3):532-7.
  8. Baloch ZW, SACK MJ, YU GH, LIVOLSI VA, GUPTA PK. Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 1998;8(7):565-9.
  9. Caraway NP, Sneige N, Samaan NA. Diagnostic pitfalls in thyroid fine‐needle aspiration: A review of 394 cases. Diagnostic cytopathology. 1993; 9(3): 345-50.
  10. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference. Diagnostic cytopathology. 2008;36(6):425-37.
  11. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. American journal of clinical pathology. 2009;132(5):658-65.
  12. Ospina NS, Brito JP, Maraka S, de Ycaza AEE, Rodriguez-Gutierrez R, Gionfriddo MR, et al. Diagnostic accuracy of ultrasound-guided fine needle aspiration biopsy for thyroid malignancy: systematic review and meta-analysis. Springer; 2016.
  13. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26(1):1-133.
  14. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta cytologica. 2012;56(4):333-9.
  15. Stelow EB, Bardales RH, Crary GS, Gulbahce HE, W. Stanley M, Savik K, et al. Interobserver variability in thyroid fine-needle aspiration interpretation of lesions showing predominantly colloid and follicular groups. American journal of clinical pathology. 2005;124(2):239-44.
  16. Padmanabhan V, Marshall CB, Akdas Barkan G, Ghofrani M, Laser A, Tolgay Ocal I, et al. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists. Diagnostic cytopathology. 2017;45(5):399-405.
  17. Ospina NS, Castaneda-Guarderas A, Ward R, Brito JP, Maraka S, Palacios CZ, et al. Patients’ knowledge about the outcomes of thyroid biopsy: a patient survey. Endocrine. 2018;61(3):482-8.
  18. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009; 19(11):1159-65.
  19. Krauss EA, Mahon M, Fede JM, Zhang L. Application of the Bethesda classification for thyroid fine-needle aspiration: institutional experience and meta-analysis. Archives of pathology & laboratory medicine. 2016;140(10):1121-31.
  20. Agarwal S, Jain D. Thyroid cytology in India: contemporary review and meta-analysis. Journal of pathology and translational medicine. 2017; 51(6): 533.
  21. Woo SH, Kim KH, Kim RB. Thyroid nodules with repeat nondiagnostic cytologic results: the role of clinical and ultrasonographic findings. World journal of surgery. 2015;39(7):1721-7.
  22. Yoon JH, Kwak JY, Kim E-K, Moon HJ, Kim MJ, Kim JY, et al. How to approach thyroid nodules with indeterminate cytology. Annals of surgical oncology. 2010;17(8):2147-55.
  23. Thewjitcharoen Y, Butadej S, Nakasatien S, Chotwanvirat P, Porramatikul S, Krittiyawong S, et al. Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)–An 8-year tertiary center experience in Thailand. Journal of clinical & translational endocrinology. 2019;16:100175.
  24. Her‐Juing Wu H, Rose C, Elsheikh TM. The Bethesda system for reporting thyroid cytopathology: an experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagnostic Cytopathology. 2012;40(5):399-403.
  25. Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery. 2011; 150(6):1234-41.
  26. Walts AE, Mirocha J, Bose S. Follicular lesion of undetermined significance in thyroid FNA revisited. Diagnostic 2014;42(1):18-22.
  27. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New England Journal of Medicine. 2012;367(8):705-15.
  28. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. The Journal of Clinical Endocrinology & Metabolism. 2011; 96(11):3390-7.
  29. Bychkov A, Hirokawa M, Jung CK, Liu Z, Zhu Y, Hong SW, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Thyroid. 2017; 27(7): 983-4.
  30. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA oncology. 2016;2(8):1023-9.
  31. Kim M, Park HJ, Min HS, Kwon HJ, Jung CK, Chae SW, et al. The use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: a nationwide multicenter survey by the Korean Society of Endocrine Pathologists. Journal of pathology and translational medicine. 2017;
    51(4): 410.
  32. Naz S, Hashmi AA, Faridi N, Edhi MM, Kamal A, Khan M. Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective. International archives of medicine. 2014;7(1):46.
Iranian Journal of Otorhinolaryngology
Volume 33, Issue 4
July and August 2021
Pages 209-215